Regulatory guidance documents, such as Annex 1 to the GMP guideline of the European Union and FDA's comparable Guidance for Industry establish the objectives to be met by pharmaceutical contamination control systems – especially those for the production of sterile medicinal drugs.
Sorry, this page is available to members only.
If you have not registered with us yet, why not
register today for FREE and receive exclusive online access. Interested in receiving European Pharmaceutical Review in print? Subscribe today and guarantee the next six issues delivered direct to your desk, plus gain exclusive access online.
